ALPHANATE®

Alphanate®

FDA INDICATION: Control and prevention of bleeding in patients with Factor VIII deficiency due to hemophilia A. Surgical and/or invasive procedures in adult and pediatric patients with von Willebrand disease (vWD) in whom desmopressin (DDAVP) is either ineffective or contraindicated. It is not indicated for patients with severe vWD (Type 3) undergoing major surgery. Package Insert

CLASS: Plasma-Derived

DISTRIBUTOR: Grifols

ASSAY SIZE (IU): FVIII: 250, 500, 1000, 1500, 2000

DILUENT SIZE: 5.0 mL (250 IU FVIII, 500 IU FVIII), 10.0 mL (1000 IU FVIII, 1500 IU FVIII)

MIXING DEVICE: Mix2Vial®

ROOM TEMPERATURE STORAGE: 36 months

OTHER WEBSITES: hemophilia.upatient.comfindthe2percent.comgrifols.comalphanate.com